MetaDx develops AI-based solutions for veterinary diagnostics, focusing on early detection of companion animal tumors. The company provides cost-effective and reliable technology designed to standardize veterinary diagnostic capabilities. Their goal is to create technology that satisfies both veterinarians and pet owners.
Funding
Funding not disclosed
KIFounders
Product
Problem
Veterinary practices face a shortage of specialized anesthesiologists, making it challenging to provide consistent, high-quality anesthesia monitoring during pet surgeries and scaling procedures. Additionally, early detection of tumors in animals can be difficult, hindering timely intervention and potentially impacting treatment outcomes.
Solution
MetaDx offers an AI-powered veterinary diagnostic platform designed to improve pet healthcare through advanced monitoring and early disease detection. The VitalVET module analyzes real-time vital signs extracted from anesthesia monitoring hardware to predict potential emergencies, determine their causes, and suggest appropriate responses, while also digitizing anesthesia records. CancerVET utilizes AI to analyze serum biomarkers, enabling early detection of tumors in pets. TraceVET provides referral testing services with internal quality control, performing tests in a reliable central laboratory.
Target Audience
The primary target audience includes veterinary clinics and hospitals seeking to improve anesthesia monitoring and early cancer detection in pets.
Features
- VitalVET: AI-based anesthesia monitoring that analyzes real-time vital signs (heart rate, respiratory rate, ECG) to predict anesthesia depth and emergency situations.
- CancerVET: AI-driven platform for early tumor detection in pets through serum biomarker analysis.
- TraceVET: Referral testing service with internal quality control standards.
- Digitization of anesthesia records through VitalVET.